The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment

Semin Cancer Biol. 2023 Jan:88:18-31. doi: 10.1016/j.semcancer.2022.11.011. Epub 2022 Nov 19.

Abstract

Signal transducer and activator of transcription (STAT) proteins compose a family of transcription factors critical for cancer stem cells (CSCs), and they are involved in maintaining stemness properties, enhancing cell proliferation, and promoting metastasis. Recent studies suggest that STAT proteins engage in reciprocal communication between CSCs and infiltrate immune cell populations in the tumor microenvironment (TME). Emerging evidence has substantiated the influence of immune cells, including macrophages, myeloid-derived suppressor cells, and T cells, on CSC survival through the regulation of STAT signaling. Conversely, dysregulation of STATs in CSCs or immune cells contributes to the establishment of an immunosuppressive TME. Thus, STAT proteins are promising therapeutic targets for cancer treatment, especially when used in combination with immunotherapy. From this perspective, we discuss the complex roles of STATs in CSCs and highlight their functions in the crosstalk between CSCs and the immune microenvironment. Finally, cutting-edge clinical trial progress with STAT signaling inhibitors is summarized.

Keywords: Cancer stem cells; STAT; Tumor microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplastic Stem Cells / metabolism
  • Transcription Factors / metabolism
  • Tumor Microenvironment

Substances

  • Transcription Factors
  • Antineoplastic Agents